Evidence map›Paper›PMID 33924621›Full record

ArticleMetabolites2021

Specialized Metabolites from Ribosome Engineered Strains of

Arshad Ali Shaikh, Louis-Felix Nothias, Santosh K Srivastava, Pieter C Dorrestein, Kapil Tahlan

Open access · goldAbstract read
In one paragraph

Article in Metabolites, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Genomic Diversity ofInternational journal of molecular sciences · 2024
    Article
  7. Article
  8. Article
  9. Microbiology spectrum · 2023
    Article
  10. Article
  11. Article
  12. Analysis ofMicrobiology spectrum · 2022
    Article
  13. Review
  14. Article
  15. Streptomyces clavuligerus: The Omics Era.Journal of industrial microbiology & biotechnology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Arshad Ali ShaikhDepartment of Biology, Memorial University of Newfoundland, St. John's, NL A1B 3X9, Canada.
Louis-Felix NothiasCollaborative Mass Spectrometry Innovation Center, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, CA 92093, USA.
Santosh K SrivastavaDepartment of Biology, Memorial University of Newfoundland, St. John's, NL A1B 3X9, Canada.
Pieter C DorresteinCollaborative Mass Spectrometry Innovation Center, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, CA 92093, USA.
Kapil TahlanDepartment of Biology, Memorial University of Newfoundland, St. John's, NL A1B 3X9, Canada.ORCID 0000-0002-2436-682X
Memorial University of Newfoundland · CAUniversity of California San Diego · US

Funding

Natural Sciences and Engineering Research Council of Canada RGPIN-2018-05949NIH HHS GM107550
6 · The paper itself

Abstract

Bacterial specialized metabolites are of immense importance because of their medicinal, industrial, and agricultural applications.

Indexed as

global molecular networkingmetabolomicsribosome engineeringribosome recycling factorspecialized metabolitesStreptomyces

Identifiers

PMID33924621
PMCPMC8069389
OpenAlexW3154101342

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.